Baricitinib in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials

E. L. Simpson, J. P. Lacour, L. Spelman, R. Galimberti, L. F. Eichenfield, R. Bissonnette, B. A. King, J. P. Thyssen, J. I. Silverberg, T. Bieber, K. Kabashima, Y. Tsunemi, A. Costanzo, E. Guttman-Yassky, L. A. Beck, J. M. Janes, A. M. DeLozier, M. Gamalo, D. R. Brinker, T. CardilloF. P. Nunes, A. S. Paller, A. Wollenberg, K. Reich

Research output: Contribution to journal › Article › peer-review

284 Scopus citations

Fingerprint

Dive into the research topics of 'Baricitinib in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials'. Together they form a unique fingerprint.

Medicine & Life Sciences